Biological seed treatment involves use of beneficial microorganisms such as bacteria, fungi, and other beneficial microbes for enhancing crop health and productivity. These microbes promote plant growth, manage diseases and pests, and improve soil conditions. Seed treatment with biofungicides and bioinsecticides protects seeds and seedlings from damage caused by soil-borne pathogens and insects. For instance, Trichoderma fungi protects plant roots from damage caused by soil-borne diseases. Similarly, Bacillus thuringiensis (Bt) controls various lepidopteran and coleopteran insect pests.
The global biological seed treatment market is estimated to be valued at US$ 1186.51 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Reduced application of chemical pesticides and availability of innovative biological seed treatments are the key drivers fueling the biological seed treatment market growth. Utilization of biofungicides and bioinsecticides helps to control seed-borne diseases and soil-borne pathogens without harming beneficial microorganisms. This prevents development of pest resistance to chemical pesticides. Furthermore, biological seed treatments are more environment-friendly compared to chemical-based treatments. Their application prevents contamination of soil and water resources.
Segment Analysis
The global biological seed treatment market is dominated by the corn sub-segment. Corn plantation occupies the largest area under cultivation amongst all crops. Biological seed treatment products help improve the yield of corn by providing necessary nutrients and protecting the seeds and young plants from diseases and pests. This drives the demand for biological seed treatment in the corn sub-segment.
PEST Analysis
Political: Governments across major agricultural nations are promoting sustainable agricultural practices and reducing the use of chemical pesticides and fertilizers. This is boosting the demand for eco-friendly biological seed treatment products.
Economic: Rising crop yield targets and shrinking cultivable land are compelling farmers to adopt advanced seed treatment techniques. This is propelling the biological seed treatment market growth.
Social: Increasing health and environmental consciousness among consumers is fueling the preference for food grains grown without or with minimal chemical inputs. This augurs well for the biological seed treatment market.
Technological: Leading players are heavily investing in R&D to develop innovative, environment-friendly and cost-effective biological seed treatment solutions. Some recent product launches include biofungicides, bioinsecticides and plant growth promoting microorganisms.
Key Takeaways
The Global Biological Seed Treatment Market Size is expected to witness high growth over the forecast period owing to supportive government policies and initiatives for sustainable agriculture.
Regionally, North America dominates the market currently owing to widespread adoption of biological seed treatment by corn farmers in the US and Canada. Europe is also a major market driven by stringent environmental norms prohibiting chemical pesticides.
Key players operating in the biological seed treatment market are Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet. Key players are focusing on developing innovative biological seed treatment formulations and solutions as well as partnerships with major seed companies to increase their market reach.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it